Tissue Distribution and Retinoid-Mediated Downregulation of an FGF-Binding Protein FGF-BP) in the Rat

References

• Baird A., Böhlen P. Fibroblast growth factors. Handbook of Experimental Pharmacology, M. B. Sporn, A. B. Roberts. Springer, New York, Berlin, Heidelberg 1990; Vol. 95/I: 369–418
   Google Scholar
• Burgess W. H., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem 1989; 58: 575–606
   PubMed Web of Science ®Google Scholar
• Chambon P. The molecular and genetic dissection of the retinoid signaling pathway. Recent. Prog. Horm. Res 1995; 50: 317–332
   PubMedGoogle Scholar
• Cordon-Cardo C., Vlodavsky I., Haimovitz-Friedman A., Hicklin D., Fuks Z. Expression of basic fibroblast growth factor in normal human tissues. Lab. Invest 1990; 63: 832–840
   PubMed Web of Science ®Google Scholar
• Czubayko F., Smith R. V., Chung H. C., Wellstein A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem 1994; 269: 28243–28248
   PubMed Web of Science ®Google Scholar
• Czubayko F., Liaudet-Coopman E. D.E., Aigner A., Tuveson A. T., Berchem G. J., Wellstein A. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer (see comments). Nature Med 1997; 3: 1137–1140
   PubMed Web of Science ®Google Scholar
• Esch F., Baird A., Ling N., Ueno N., Hill F., Denoroy L., Klepper R., Gospodarowicz D., Bohlen P., Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc. Natl. Acad. Sci. USA 1985; 82: 6507–6511
   PubMed Web of Science ®Google Scholar
• Folkman J., Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–447
   PubMed Web of Science ®Google Scholar
• Gonzalez A. M., Berry M., Maher P. A., Logan A., Baird A. A comprehensive analysis of the distribution of FGF-2 and FGFRI in the rat brain. Brain Res 1995; 701: 201–226
   PubMed Web of Science ®Google Scholar
• Guillonneau X., Regnier-Ricard F., Laplace O., Jonet L., Bryckaert M., Courtois Y., Mascarelli F. Fibroblast growth factor (FGF) soluble receptor 1 acts as a naturla inhibitor of FGF2 neurotrophic activity during retinal degeneration. Mol. Biol. Cell 1998; 9: 2785–2802
   PubMed Web of Science ®Google Scholar
• Khuri F. R., Lippman S. M., Spitz M. R., Lotan R., Hong W. K. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J. Natl. Cancer Inst 1997; 89: 199–211
   PubMedGoogle Scholar
• Kiefer M. C., Stephans J. C., Crawford K., Okino K., Barr P. J. Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 1990; 87: 6985–6989
   PubMed Web of Science ®Google Scholar
• Kozak M. An analysis of 5′-noncodingsequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125–8148
   PubMed Web of Science ®Google Scholar
• Kurtz A., Darwiche N., Harris V., Wang H. L., Wellstein A. Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis. Oncogene 1997; 14: 2671–2681
   Google Scholar
• Liaudet-Coopman E. D.E., Wellstein A. Regulation of gene expression of a binding protein for fibroblast growth factor by retinoic acid. J. Biol. Chem 1996; 271: 21303–21308
   Google Scholar
• Liaudet-Coopman E. D.E., Schulte A. M., Cardillo M., Wellstein A. A tetracycline-responsive promoter system reveals the role of a secreted binding protein for FGFs during the early phase of tumor growth. Biochem. Biophys. Res. Commun 1996; 229: 930–937
   Google Scholar
• Liaudet-Coopman E. D.E., Berchem G. J., Wellstein A. In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma. Clin. Cancer Res 1997; 3: 179–184
   PubMed Web of Science ®Google Scholar
• Lobb R., Fett J. Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. Biochemistry 1984; 23: 6295–6299
   PubMed Web of Science ®Google Scholar
• Maciag T., Tevie M., Friesel R. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science 1984; 225: 932–935
   PubMed Web of Science ®Google Scholar
• Mason I. J. The ins and outs of fibroblast growth factors. Cell 1994; 78: 547–552
   PubMed Web of Science ®Google Scholar
• Matsuda S., Okumura N., Yoshimura H., Koyama Y., Sakanaka M. Basic fibroblast growth factor-like immunoreactivity in Purkinje cells of the rat cerebellum. Neuroscience 1992; 50: 99–106
   Google Scholar
• Miller W. H., Jr. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 1998; 83: 1471–1482
   PubMed Web of Science ®Google Scholar
• Moscatelli D., Presta M., Joseph-Silverstein J., Rifkin D. B. Both normal and tumor cells produce basic fibroblast growth factor. J. Cell Physiol 1986; 129: 273–276
   PubMed Web of Science ®Google Scholar
• Patterson S. L., Grady M. S., Bothwell M. Nerve growth factor and a fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients. Brain Res 1993; 605: 43–49
   PubMed Web of Science ®Google Scholar
• Rak J., Kerbel R. S. bFGF and tumor angiogenesis - back in the limelight? (news; comment). Nature Med 1997; 3: 1083–1084
   PubMedGoogle Scholar
• Risau W. Developing brain produces an angiogenesis factor. Proc. Natl. Acad. Sci. USA 1986; 83: 3855–3859
   PubMed Web of Science ®Google Scholar
• Risau W., Gautschi-Sova P., Bohlen P. Endothelial cell growth factors in embryonic and adult chick brain are related to human acidic fibroblast growth factor. EMBO J 1988; 7: 959–962
   PubMed Web of Science ®Google Scholar
• Rogelj S., Klagsbrun M., Atzmon R., Kurokawa M., Haimovitz A., Fuks Z., Vlodavsky I. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation ot PC 12 cells. J. Cell Biol 1989; 109: 823–831
   PubMed Web of Science ®Google Scholar
• Saksela O., Moscatelli D., Sommer A., Rifkin D. B. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol 1988; 107: 743–751
   PubMed Web of Science ®Google Scholar
• Shing Y., Folkman J., Sullivan R., Butterfield C., Murray J., Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223: 1296–1299
   PubMed Web of Science ®Google Scholar
• Vlodavsky I., Folkman J., Sullivan R., Fridman R., Ishai-Michaeli R., Sasse J., Klagsbun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 1987; 84: 2292–2296
   PubMed Web of Science ®Google Scholar
• Wellstein A., Czubayko F. Inhibition of fibroblast growth factors. Breast Cancer Res. Treat 1996; 38: 109–119
   PubMed Web of Science ®Google Scholar
• Wu D., Kann M., Sato G. H., Okamoto T., Sato J. D. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem 1991; 266: 16778–16785
   PubMed Web of Science ®Google Scholar